Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

September 14, 2016

California Urologist Now Uses UroLift System to Help BPH Patients

News

Patients at the Southern California Urology Institute in West Hills, Calif., are now being treated with the UroLift System, according to founder/director Gary Bellman, MD. UroLift was approved by the U.S. ... Read more

September 9, 2016

Generic Version of BPH Treatment, Cialis, Expected to Soon Enter Clinical Testing

News

VMS Rehab Systems announced that its generic drug unit, BioPharmcor BV, has made significant progress in its formulation program to develop a generic version of Cialis (tadalafil), a treatment for patients of erectile ... Read more

August 25, 2016

First Patients Enrolled in Study to Expand Indications for Spanner Prostate Stent

News

The first patients in a new investigational device exemption (IDE) study to expand indications for SRS Medical Systems‘ Spanner Temporary Prostatic Stent have been enrolled. The stent is a U.S. Food and Drug Administration (FDA) approved ... Read more

August 22, 2016August 22, 2016

Powder Treatment for BPH, Tamsulosin DRS, to Get Speedy FDA Review

News

Aspen Park Pharmaceuticals (APP) announced that the U.S. Food and Drug Administration (FDA) has agreed to an expedited regulatory review process for Tamsulosin DRS, the pharmaceutical’s lead powder formulation of the widely ... Read more

May 17, 2016May 17, 2016

NeoTract Presents Latest Clinical Data on the UroLift System to Treat BPH/LUTS

News

NeoTract, Inc., presented new and favorable clinical data from two randomized studies of its UroLift system in treating the symptoms of benign prostate hyperplasia (BPH). The presentations were made at the recent American Urological Association ... Read more

May 13, 2016May 13, 2016

Sophiris Presents Positive Data from Phase 3 Study of LUTS Drug Treatment at AUA 2016

News

Sophiris Bio, Inc., presented positive data from its ongoing Phase 3 clinical trial of topsalysin — assessing the drug candidate as a potential treatment for symptoms of benign prostatic hyperplasia (BPH) — as a ... Read more

May 2, 2016May 2, 2016

St. Jude Medical Center Offering UroLift Procedure to BPH Patients in Southern California

News

St. Jude Medical Center urologists are among the first in their Southern California region to now offer UroLift, a minimally invasive treatment to correct low or blocked urine flow due to ... Read more

March 14, 2016May 13, 2016

10-Minute Treatment for Enlarged Prostate Now Available to BPH Patients in Colorado

News

Urology Associates of Denver is the first clinic in Colorado and as one of the few in the U.S. to provide a 1o-minute treatment called Rezūm to its patients. The therapy uses natural energy stored ... Read more

March 3, 2016May 13, 2016

Generic Version of BPH Drug, Tadalafil, Being Readied for Testing in Clinical Trials

News

VMS Rehab Systems, Inc., reported that its generic drug subsidiary, BioPharmcor BV, in the final development and preclinical testing stages for it generic version of tadalafil, a potential first-line treatment for men with erectile dysfunction ... Read more

February 4, 2016May 13, 2016

FDA Approval of Generic Drug Offers Hope for BPH Patients,

News

Unichem Laboratories has announced it has received final Abbreviated New Drug Application (ANDA) approval from the U.S. FDA for a drug for the treatment of benign prostatic hyperplasia (BPH) in ... Read more